Assessing the accuracy of [18F]PSMA-1007 PET/CT for primary staging of lymph node metastases in intermediate- and high-risk prostate cancer patients

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
2191-219X
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
Assessing the accuracy of [18F]PSMA-1007 PET/CT for primary staging of lymph node metastases in intermediate- and high-risk prostate cancer patients ; volume:12 ; number:1 ; day:9 ; month:8 ; year:2022 ; pages:1-8 ; date:12.2022
EJNMMI Research ; 12, Heft 1 (9.8.2022), 1-8, 12.2022

Urheber
Ingvar, Jacob
Hvittfeldt, Erland
Trägårdh, Elin
Simoulis, Athanasios
Bjartell, Anders
Beteiligte Personen und Organisationen
SpringerLink (Online service)

DOI
10.1186/s13550-022-00918-7
URN
urn:nbn:de:101:1-2022102812580641885727
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
15.08.2025, 07:30 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Ingvar, Jacob
  • Hvittfeldt, Erland
  • Trägårdh, Elin
  • Simoulis, Athanasios
  • Bjartell, Anders
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Risk of metastatic disease using [18F]PSMA-1007 PET/CT for primary prostate cancer staging

Risk of metastatic disease using [18F]PSMA-1007 PET/CT for primary prostate cancer staging

The value of 18F-PSMA-1007 PET/CT in identifying non-metastatic high-risk prostate cancer

The value of 18F-PSMA-1007 PET/CT in identifying non-metastatic high-risk prostate cancer

Multiparametric dynamic whole-body PSMA PET/CT using [68Ga]Ga-PSMA-11 and [18F]PSMA-1007

Multiparametric dynamic whole-body PSMA PET/CT using [68Ga]Ga-PSMA-11 and [18F]PSMA-1007

Prospective comparison of 18F-PSMA-1007 PET/CT, whole-body MRI and CT in primary nodal staging of unfavourable intermediate- and high-risk prostate cancer

Prospective comparison of 18F-PSMA-1007 PET/CT, whole-body MRI and CT in primary nodal staging of unfavourable intermediate- and high-risk prostate cancer

68Ga-PSMA I&T PET/CT for primary staging of prostate cancer

68Ga-PSMA I&T PET/CT for primary staging of prostate cancer

Meta-analysis of 18 F-PSMA-1007 PET/CT, 18 F-FDG PET/CT, and 68Ga-PSMA PET/CT in diagnostic efficacy of prostate Cancer

Meta-analysis of 18 F-PSMA-1007 PET/CT, 18 F-FDG PET/CT, and 68Ga-PSMA PET/CT in diagnostic efficacy of prostate Cancer

18F-JK-PSMA-7 PET/CT for staging intermediate- or high-risk prostate cancer patients before radical prostatectomy: a pilot study

18F-JK-PSMA-7 PET/CT for staging intermediate- or high-risk prostate cancer patients before radical prostatectomy: a pilot study

68Ga-PSMA I&T PET/CT for primary staging of prostate cancer [Abstract]

68Ga-PSMA I&T PET/CT for primary staging of prostate cancer [Abstract]

Diagnostic accuracy of [18F]PSMA-1007 PET/CT in biochemical recurrence of prostate cancer

Diagnostic accuracy of [18F]PSMA-1007 PET/CT in biochemical recurrence of prostate cancer

PSMA-Liganden PET/CT bei Patienten mit biochemischem Rezidiv nach radikaler Prostatektomie: Matched-Pair Vergleich von 68Ga-PSMA-11 und 18F-PSMA-1007

PSMA-Liganden PET/CT bei Patienten mit biochemischem Rezidiv nach radikaler Prostatektomie: Matched-Pair Vergleich von 68Ga-PSMA-11 und 18F-PSMA-1007

PET/CT imaging 2 h after injection of [18F]PSMA-1007 can lead to higher staging of prostate cancer than imaging after 1 h

PET/CT imaging 2 h after injection of [18F]PSMA-1007 can lead to higher staging of prostate cancer than imaging after 1 h

Comparison of 68Ga-PSMA-11 PET-CT with mpMRI for preoperative lymph node staging in patients with intermediate to high-risk prostate cancer

Comparison of 68Ga-PSMA-11 PET-CT with mpMRI for preoperative lymph node staging in patients with intermediate to high-risk prostate cancer

Verbundene Objekte